Mesoblast Limited (MESO)

Mesoblast Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 25, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,970	1,386	754	615	273	961
Market Cap Growth	99.74%	83.84%	22.64%	125.02%	-71.58%	-26.21%
Enterprise Value	1,938	1,479	797	680	299	905
Last Close Price	16.06	10.89	6.81	7.82	4.44	14.96
PS Ratio	114.57	80.58	127.72	81.94	26.75	129.28
PB Ratio	3.30	2.32	1.57	1.23	0.55	1.65
P/TBV Ratio	76.92	54.10	-	-	-	1129.32
EV/Sales Ratio	112.66	86.01	135.09	90.65	29.26	121.80
Debt / Equity Ratio	0.22	0.22	0.25	0.23	0.22	0.18
Asset Turnover	0.02	0.02	0.01	0.01	0.02	0.01
Quick Ratio	1.72	1.72	1.14	1.85	1.25	1.50
Current Ratio	1.99	1.99	1.18	1.95	1.36	1.57
Return on Equity (ROE)	-18.95%	-18.95%	-17.91%	-16.40%	-16.94%	-17.48%
Return on Assets (ROA)	-5.37%	-5.37%	-5.41%	-6.50%	-7.16%	-9.22%
Return on Capital (ROIC)	-5.89%	-5.89%	-5.95%	-7.09%	-7.80%	-10.21%
Return on Capital Employed (ROCE)	-9.20%	-9.20%	-9.70%	-11.00%	-13.20%	-16.80%
Earnings Yield	-5.18%	-7.37%	-11.67%	-13.32%	-33.44%	-10.28%
FCF Yield	-2.57%	-3.65%	-6.46%	-10.34%	-24.14%	-10.66%
Buyback Yield / Dilution	-22.41%	-22.41%	-26.87%	-13.89%	-12.86%	-14.42%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q